Enantiomeric impurities in chiral synthons, catalysts, and auxiliaries. Part 3. - Wikidata - awgldk - TriplyDB

Enantiomeric impurities in chiral synthons, catalysts, and auxiliaries. Part 3.

Enantiomeric impurities in chiral synthons, catalysts, and auxiliaries. Part 3.

http://www.wikidata.org/entity/Q34961029

about

Enantiomeric separation of biaryl atropisomers using cyclofructan based chiral stationary phases.Determination of optical purity of 3,5-dimethoxybenzoyl-leucine diethylamide by chiral chromatography and 1H and 13C NMR spectroscopy.Enantioseparation of citalopram analogues with sulfated β-cyclodextrin by capillary electrophoresis.

P2860

Q33992309-0423222B-8207-409F-B7ED-83B24635AEAD Q43480843-62592117-CA19-4152-B3E1-3ADE004EA7AB Q51565470-F84F0F65-9080-443B-8F79-E3176D22074D

P2860

Enantiomeric impurities in chiral synthons, catalysts, and auxiliaries. Part 3.

http://www.wikidata.org/entity/Q34961029

description

2006 nî lūn-bûn

@nan

2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Enantiomeric impurities in chiral synthons, catalysts, and auxiliaries. Part 3.

@ast

Enantiomeric impurities in chiral synthons, catalysts, and auxiliaries. Part 3.

@en

Enantiomeric impurities in chiral synthons, catalysts, and auxiliaries. Part 3.

@nl

type

label

Enantiomeric impurities in chiral synthons, catalysts, and auxiliaries. Part 3.

@ast

Enantiomeric impurities in chiral synthons, catalysts, and auxiliaries. Part 3.

@en

Enantiomeric impurities in chiral synthons, catalysts, and auxiliaries. Part 3.

@nl

prefLabel

Enantiomeric impurities in chiral synthons, catalysts, and auxiliaries. Part 3.

@ast

Enantiomeric impurities in chiral synthons, catalysts, and auxiliaries. Part 3.

@en

Enantiomeric impurities in chiral synthons, catalysts, and auxiliaries. Part 3.

@nl

P1433

Q34961029-61931ACF-0944-48F3-B8B4-C57C33DF8BB2

P1476

Q34961029-31D69AE7-459E-49CB-A181-C966AB3D610B

P2093

Q34961029-935064EC-FE80-4A0D-8D53-192602FD0B71

Q34961029-A6F8EC88-76CA-4744-9359-B449267E677F

Q34961029-CEFC1D7F-3F32-48C9-9686-8CFA04B5084F

P2860

Q34961029-026C83F4-73AF-46A2-BA78-2C201A7A0A82

Q34961029-05417754-DF43-41C6-B526-0FB5DB823629

Q34961029-0F91FDF9-CDF4-4034-B9EF-CBE0BF4A9935

Q34961029-166E25C2-C703-440C-B824-214D5B194414

Q34961029-16F13915-26B9-45EB-B4D0-63D937AF011B

Q34961029-1A50702C-0027-4360-8347-D1BBA87D95A0

Q34961029-22B496DE-17B2-44EC-BECA-7B49F8D54975

Q34961029-28652C95-966B-45DD-90CF-6B0545C8FA13

Q34961029-3AAA2239-FBCF-4F98-9277-65973DDB2CEE

Q34961029-3BF6F169-A108-4216-A8AC-68EB57C2B269

P304

Q34961029-8FDA4F40-EB93-4A19-ABF4-9DEDF30399F2

P31

Q34961029-C536FF12-0712-4570-B700-7D398910EEF5

P356

Q34961029-8A265FF9-D424-4803-9AE1-99F054E65C8E

P433

Q34961029-750315A2-72F5-4B2D-A351-E92293F3FB71

P478

Q34961029-922AC663-4CB3-4BD4-A048-ED30EFC4A46E

P577

Q34961029-11A88D3A-DC16-474D-830B-BB3A7DCC4128

P698

Q34961029-35901DC8-FA4F-4C57-8AA0-EE9889977E56

P932

Q34961029-5E5F9ABC-0605-4695-A239-DB698A375E94

P356

J.TETASY.2006.10.014

P1433

Tetrahedron: Asymmetry

P1476

Enantiomeric impurities in chiral synthons, catalysts, and auxiliaries. Part 3.

@en

P2093

Daniel W Armstrong

http://www.w3.org/2001/XMLSchema#string

Ke Huang

http://www.w3.org/2001/XMLSchema#string

Zachary S Breitbach

http://www.w3.org/2001/XMLSchema#string

P2860

4,5-Disubstituted-1,3-oxazolidin-2-imine derivatives: a new class of orally bioavailable nitric oxide synthase inhibitor

Oligonucleotides containing 2'-O-[2-(2,3-dihydroxypropyl)amino-2-oxoethyl]uridine as suitable precursors of 2'-aldehyde oligonucleotides for chemoselective ligation.

Synthesis of new 3'-, 5-, and N(4)-modified 2'-O-methylcytidine libraries on solid support.

Synthesis and structure-activity relationships of novel arylpiperazines as potent and selective agonists of the melanocortin subtype-4 receptor.

Synthesis of long-chain amide analogs of the cannabinoid CB1 receptor antagonist N-(piperidinyl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716) with unique binding selectivities and pharmacological activities

Synthesis and structure-activity relationship of ethacrynic acid analogues on glutathione-s-transferase P1-1 activity inhibition.

Synthesis and structure-activity-relationships of 1H-imidazo[4,5-c]quinolines that induce interferon production.

Imidazole analogues of fluoxetine, a novel class of anti-Candida agents.

4,5-dialkylsubstituted 2-imino-1,3-thiazolidine derivatives as potent inducible nitric oxide synthase inhibitors.

Synthesis and structure-activity relationships of novel 7-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acids as antitumor agents. Part 2.

P304

2821-2832

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.TETASY.2006.10.014

http://www.w3.org/2001/XMLSchema#string

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2006-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25598583

http://www.w3.org/2001/XMLSchema#string

P932

4294700

http://www.w3.org/2001/XMLSchema#string